首页 > 最新文献

Advances in Traditional Medicine最新文献

英文 中文
Combining Chinese and Persian medicine techniques of cupping in hospitalized COVID-19 patients: a single-blind, randomized, controlled trial 中西医结合拔罐治疗新冠肺炎住院患者的单盲随机对照试验
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-16 DOI: 10.1007/s13596-023-00693-3
Reihane Alipour, Mehrdad Karimi, MohammadSadegh Adel-Mehraban, Assie Jokar, Mohebat Vali, AmirHooman Kazemi

COVID-19 pneumonia and long COVID is commonly associated with cough, dyspnea and declined oxygen saturation (SpO2). Cupping has been used as an adjuvant therapy to improve SpO2 and respiratory symptoms. This research was conducted as an assessor- and analyst-blinded, randomized controlled trial. A total of 72 hospitalized patients with moderate-to-severe COVID-19 were randomly assigned into two groups: (1) cupping (CUPP); and (2) control (CTRL), all receiving conventional treatment. In CUPP, warm cupping was performed for 3–7 days (three times, daily). The primary clinical outcomes were SpO2 and respiratory rate (RR). COVID-19-related hospitalization duration, intensive care unit admission and duration, need for intubation, and mortality (all up to day 28) were evaluated as secondary efficacy endpoints. Furthermore, severity of cough, dyspnea, chest tightness, and oxygen demand were considered as secondary outcomes. Thirty-four patients in CUPP and 33 patients in CTRL completed the study. After 3 days, RR decreased in CUPP significantly (p < 0.001), unlike CTRL (p > 0.05). After 7 days of intervention, SpO2 improved up to 13% in CUPP versus 0.07% in CTRL (p < 0.001). Compared with CTRL, patients in CUPP were discharged sooner (mean: 12.1 vs. 3.9, respectively) and faced no serious adverse events (p < 0.001). Moreover, after 28 days of follow-up, all CUPP patients were discharged from the hospital. In contrast, eight patients from the CTRL expired. Within 3 days, respiratory symptoms improved significantly in CUPP compared with CTRL (p < 0.05). Adjuvant cupping therapy accelerates alleviation of respiratory symptoms and prevents morbidities and mortalities in COVID-19 patients.

COVID-19肺炎和长COVID通常伴有咳嗽、呼吸困难和血氧饱和度(SpO2)下降。拔罐疗法已被用作改善 SpO2 和呼吸道症状的辅助疗法。这项研究是一项由评估者和分析者双盲的随机对照试验。共有 72 名中重度 COVID-19 住院患者被随机分配到两组:(1) 拔罐组(CUPP);(2) 对照组(CTRL),所有患者均接受常规治疗。在 CUPP 组中,拔罐疗法持续 3-7 天(每天三次)。主要临床结果为SpO2和呼吸频率(RR)。与 COVID-19 相关的住院时间、重症监护室入院时间、插管需求和死亡率(均截至第 28 天)作为次要疗效终点进行评估。此外,咳嗽、呼吸困难、胸闷和需氧量的严重程度也被视为次要结果。34 名 CUPP 患者和 33 名 CTRL 患者完成了研究。3 天后,CUPP 的 RR 显著下降(p < 0.001),而 CTRL 则不同(p > 0.05)。干预 7 天后,CUPP 的 SpO2 改善达 13%,而 CTRL 仅为 0.07%(p < 0.001)。与 CTRL 相比,CUPP 患者出院时间更早(平均出院时间为 12.1 天,CTRL 患者为 3.9 天),且未发生严重不良事件(p < 0.001)。此外,经过 28 天的随访,所有 CUPP 患者均已出院。相比之下,CTRL 有 8 名患者死亡。在 3 天内,与 CTRL 相比,CUPP 患者的呼吸道症状明显改善(p < 0.05)。辅助拔罐疗法可加速缓解 COVID-19 患者的呼吸道症状,并预防发病和死亡。
{"title":"Combining Chinese and Persian medicine techniques of cupping in hospitalized COVID-19 patients: a single-blind, randomized, controlled trial","authors":"Reihane Alipour,&nbsp;Mehrdad Karimi,&nbsp;MohammadSadegh Adel-Mehraban,&nbsp;Assie Jokar,&nbsp;Mohebat Vali,&nbsp;AmirHooman Kazemi","doi":"10.1007/s13596-023-00693-3","DOIUrl":"10.1007/s13596-023-00693-3","url":null,"abstract":"<div><p>COVID-19 pneumonia and long COVID is commonly associated with cough, dyspnea and declined oxygen saturation (SpO<sub>2</sub>). Cupping has been used as an adjuvant therapy to improve SpO<sub>2</sub> and respiratory symptoms. This research was conducted as an assessor- and analyst-blinded, randomized controlled trial. A total of 72 hospitalized patients with moderate-to-severe COVID-19 were randomly assigned into two groups: (1) cupping (CUPP); and (2) control (CTRL), all receiving conventional treatment. In CUPP, warm cupping was performed for 3–7 days (three times, daily). The primary clinical outcomes were SpO<sub>2</sub> and respiratory rate (RR). COVID-19-related hospitalization duration, intensive care unit admission and duration, need for intubation, and mortality (all up to day 28) were evaluated as secondary efficacy endpoints. Furthermore, severity of cough, dyspnea, chest tightness, and oxygen demand were considered as secondary outcomes. Thirty-four patients in CUPP and 33 patients in CTRL completed the study. After 3 days, RR decreased in CUPP significantly (<i>p</i> &lt; 0.001), unlike CTRL (<i>p</i> &gt; 0.05). After 7 days of intervention, SpO<sub>2</sub> improved up to 13% in CUPP versus 0.07% in CTRL (<i>p</i> &lt; 0.001). Compared with CTRL, patients in CUPP were discharged sooner (mean: 12.1 vs. 3.9, respectively) and faced no serious adverse events (<i>p</i> &lt; 0.001). Moreover, after 28 days of follow-up, all CUPP patients were discharged from the hospital. In contrast, eight patients from the CTRL expired. Within 3 days, respiratory symptoms improved significantly in CUPP compared with CTRL (<i>p</i> &lt; 0.05). Adjuvant cupping therapy accelerates alleviation of respiratory symptoms and prevents morbidities and mortalities in COVID-19 patients.</p></div>","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"24 1","pages":"253 - 263"},"PeriodicalIF":1.8,"publicationDate":"2023-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47341214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Ethnomedicinal review of plants utilized by the Abagusii people of Western Kenya 修正:肯尼亚西部Abagusii人使用的植物的民族医学综述
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-10 DOI: 10.1007/s13596-023-00694-2
Jared Misonge Onyancha, Gervason Apiri Moriasi, Vincent Obaga Nyandoro, Brenda Monchari Onyancha, James Meroka Onsinyo
{"title":"Correction to: Ethnomedicinal review of plants utilized by the Abagusii people of Western Kenya","authors":"Jared Misonge Onyancha,&nbsp;Gervason Apiri Moriasi,&nbsp;Vincent Obaga Nyandoro,&nbsp;Brenda Monchari Onyancha,&nbsp;James Meroka Onsinyo","doi":"10.1007/s13596-023-00694-2","DOIUrl":"10.1007/s13596-023-00694-2","url":null,"abstract":"","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"24 1","pages":"387 - 387"},"PeriodicalIF":1.8,"publicationDate":"2023-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44244478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence approach in identification of differentially expressed genes of methyl glycoside against myocardial infarction 人工智能方法鉴定甲基糖苷抗心肌梗死差异表达基因
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-10 DOI: 10.1007/s13596-023-00691-5
Sreya Kosanam, Rajeshwari Pasupula

To predict the targets of small molecules from traditional plants using an artificial intelligence (AI) approach for myocardial infarction. In this study, we used different web servers and software to predict the targets of small molecule from plant of interest. The methanolic extract of Aganosma dichotoma was screened and the presence of small molecules was confirmed by GC–MS analysis. In this study, Methyl beta d-xylopyranoside is a Methyl glycoside, which was identified as a small molecule (164.16 gms/mol). Pharmacokinetic and toxicity prediction of methyl glycoside showed good bioavailability, accepting the five rules of Lipinki and LD50 ≥ 5000 mg/kg. Differentially expressed genes were identified from the datasets and overlapping genes were assessed for gene enrichment analysis pathways with p < 0.05. A PPI network was constructed and hub genes were identified. Anti-oxidant potency of small molecule is validated through in-vitro anti-oxidant activity through DPPH and ABTS analysis where, small molecule DPPH, ABTS activity was reported to have an IC50 value of 51.09%, 80.67% and 48.41%, 90.19% at 0.1 μM/ml, 0.5 μM/ml concentrations respectively. The small molecule methyl beta d-xylopyranoside is a robust antioxidant that may act against myocardial infarction caused by ischemia and free radical generation, but needs to be validated through further in vivo studies.

利用人工智能(AI)方法从传统植物中预测治疗心肌梗塞的小分子靶标。在这项研究中,我们使用了不同的网络服务器和软件来预测相关植物小分子的靶点。我们对 Aganosma dichotoma 的甲醇提取物进行了筛选,并通过气相色谱-质谱分析确认了小分子的存在。在这项研究中,甲基 beta d-xylopyranoside 是一种甲基苷,被鉴定为小分子(164.16 gms/mol)。甲基糖苷的药代动力学和毒性预测结果表明,其生物利用度良好,符合 Lipinki 的五项规则,半数致死剂量≥ 5000 毫克/千克。从数据集中确定了差异表达基因,并对重叠基因进行了基因富集分析通路评估(p < 0.05)。构建了一个 PPI 网络,并确定了枢纽基因。通过 DPPH 和 ABTS 分析,体外抗氧化活性验证了小分子的抗氧化效力,据报道,小分子 DPPH 和 ABTS 活性在 0.1 μM/ml 和 0.5 μM/ml 浓度下的 IC50 值分别为 51.09%、80.67% 和 48.41%、90.19%。小分子甲基 beta d-xylopyranoside 是一种强有力的抗氧化剂,可能对缺血和自由基生成引起的心肌梗死有作用,但还需要通过进一步的体内研究来验证。
{"title":"Artificial intelligence approach in identification of differentially expressed genes of methyl glycoside against myocardial infarction","authors":"Sreya Kosanam,&nbsp;Rajeshwari Pasupula","doi":"10.1007/s13596-023-00691-5","DOIUrl":"10.1007/s13596-023-00691-5","url":null,"abstract":"<div><p>To predict the targets of small molecules from traditional plants using an artificial intelligence (AI) approach for myocardial infarction. In this study, we used different web servers and software to predict the targets of small molecule from plant of interest. The methanolic extract of <i>Aganosma dichotoma</i> was screened and the presence of small molecules was confirmed by GC–MS analysis. In this study, Methyl beta <span>d</span>-xylopyranoside is a Methyl glycoside, which was identified as a small molecule (164.16 gms/mol). Pharmacokinetic and toxicity prediction of methyl glycoside showed good bioavailability, accepting the five rules of Lipinki and LD50 ≥ 5000 mg/kg. Differentially expressed genes were identified from the datasets and overlapping genes were assessed for gene enrichment analysis pathways with <i>p</i> &lt; 0.05. A PPI network was constructed and hub genes were identified. Anti-oxidant potency of small molecule is validated through in-vitro anti-oxidant activity through DPPH and ABTS analysis where, small molecule DPPH, ABTS activity was reported to have an IC50 value of 51.09%, 80.67% and 48.41%, 90.19% at 0.1 μM/ml, 0.5 μM/ml concentrations respectively. The small molecule methyl beta <span>d</span>-xylopyranoside is a robust antioxidant that may act against myocardial infarction caused by ischemia and free radical generation, but needs to be validated through further in vivo studies.</p></div>","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"24 1","pages":"243 - 252"},"PeriodicalIF":1.8,"publicationDate":"2023-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47451060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastro-protective effects and anti-Helicobacter pylori activities of the aqueous and methanol extracts of the stem-back of Nauclea pobeguinii (Rubiaceae) 江蓠茎背水提物和甲醇提物的胃保护作用及抗幽门螺杆菌活性
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-03 DOI: 10.1007/s13596-023-00686-2
Madjo Kouam Yacine Karelle, Mbiantcha Marius, Fagni Njoya Zenab Linda, Matah Marthe Vanessa Mba, Ngoufack Azanze Elvira, Tsafack Eric Gonzal, Djuichou Nguemnang Stephanie Flore, Adjouzem Carine Flore, Ateufack Gilbert

Nauclea pobeguinii (N. pobeguinii) is a plant used in African medicine to treat many gastroduodenal diseases. In this study, we determined the gastro-protective mechanisms and anti-Helicobacter pylori (H. pylori) properties of N. pobeguinii extracts. Wound healing activity (acetic acid test), anti-secretory properties (pyloric ligation, pyloric ligation/acetylcholine and pyloric ligation/histamine tests) and cytoprotective effects (ethanol test) were assessed in female rat, the anti-Helicobacter pylori (agar well diffusion method) was also evaluated. At doses of 100, 200 and 400 mg/kg, the extracts reduce (p < 0.001) the various ulceration parameters. In the acetic acid test, the extracts (200 mg/kg) reduced ulcerated areas by 99.23% (aqueous) and by 98.47% (methanol), levels of monocytes, lymphocytes, nitrogen, malondialdehyde and increased (p < 0.001) superoxide dismutase and catalase activities. Histological analysis showed repair of the mucosal epithelium at all doses of both extracts. Aqueous and methanol extracts inhibited ulceration indices by 99.68 and 99.33% (pyloric ligation), 83.81% and 61.07% (pyloric ligation/acetylcholine), 97.49% and 98.50% (pylorus ligation/histamine); they increased (p < 0.001) the mucus mass and uterine mass. In vitro, the different H. pylori isolates were sensitive to both extracts; the aqueous extract showed strong anti-urease activity, a large diameter of the inhibitory zone and a better minimum inhibitory concentration. Aqueous and methanolic extracts of N. pobeguinii healed ulcers through their estrogen-modulating anti-inflammatory, antioxidant, anti-secretory and cytoprotective properties. The aqueous extract of N. pobeguinii could be a good solution for the treatment of this infection.

在非洲医学中,Nauclea pobeguinii(N. pobeguinii)是一种用于治疗多种胃十二指肠疾病的植物。在这项研究中,我们确定了 N. pobeguinii 提取物的胃保护机制和抗幽门螺旋杆菌(H. pylori)特性。在雌性大鼠身上评估了伤口愈合活性(醋酸试验)、抗分泌特性(幽门结扎、幽门结扎/乙酰胆碱和幽门结扎/组胺试验)和细胞保护作用(乙醇试验),还评估了抗幽门螺旋杆菌的作用(琼脂井扩散法)。在剂量为 100、200 和 400 毫克/千克时,提取物可降低各种溃疡参数(p < 0.001)。在醋酸试验中,提取物(200 毫克/千克)减少了 99.23% 的溃疡面积(水溶液)和 98.47% 的溃疡面积(甲醇),降低了单核细胞、淋巴细胞、氮、丙二醛的水平,并提高了(p < 0.001)超氧化物歧化酶和过氧化氢酶的活性。组织学分析表明,所有剂量的两种提取物都能修复粘膜上皮。水提取物和甲醇提取物对溃疡指数的抑制率分别为 99.68% 和 99.33%(幽门结扎)、83.81% 和 61.07%(幽门结扎/乙酰胆碱)、97.49% 和 98.50%(幽门结扎/组胺);它们增加了粘液质量和子宫质量(p < 0.001)。在体外,不同的幽门螺杆菌分离物对这两种提取物都很敏感;水提取物显示出很强的抗尿素酶活性,抑制区直径大,最低抑制浓度更高。N. pobeguinii的水提取物和甲醇提取物具有调节雌激素的抗炎、抗氧化、抗分泌和细胞保护作用,可治愈溃疡。波贝金尼的水提取物可以很好地解决这种感染的治疗问题。
{"title":"Gastro-protective effects and anti-Helicobacter pylori activities of the aqueous and methanol extracts of the stem-back of Nauclea pobeguinii (Rubiaceae)","authors":"Madjo Kouam Yacine Karelle,&nbsp;Mbiantcha Marius,&nbsp;Fagni Njoya Zenab Linda,&nbsp;Matah Marthe Vanessa Mba,&nbsp;Ngoufack Azanze Elvira,&nbsp;Tsafack Eric Gonzal,&nbsp;Djuichou Nguemnang Stephanie Flore,&nbsp;Adjouzem Carine Flore,&nbsp;Ateufack Gilbert","doi":"10.1007/s13596-023-00686-2","DOIUrl":"10.1007/s13596-023-00686-2","url":null,"abstract":"<div><p><i>Nauclea pobeguinii</i> (<i>N. pobeguinii</i>) is a plant used in African medicine to treat many gastroduodenal diseases. In this study, we determined the gastro-protective mechanisms and anti-<i>Helicobacter pylori</i> (<i>H. pylori</i>) properties of <i>N. pobeguinii</i> extracts. Wound healing activity (acetic acid test), anti-secretory properties (pyloric ligation, pyloric ligation/acetylcholine and pyloric ligation/histamine tests) and cytoprotective effects (ethanol test) were assessed in female rat, the anti-<i>Helicobacter pylori</i> (agar well diffusion method) was also evaluated. At doses of 100, 200 and 400 mg/kg, the extracts reduce (<i>p</i> &lt; 0.001) the various ulceration parameters. In the acetic acid test, the extracts (200 mg/kg) reduced ulcerated areas by 99.23% (aqueous) and by 98.47% (methanol), levels of monocytes, lymphocytes, nitrogen, malondialdehyde and increased (<i>p</i> &lt; 0.001) superoxide dismutase and catalase activities. Histological analysis showed repair of the mucosal epithelium at all doses of both extracts. Aqueous and methanol extracts inhibited ulceration indices by 99.68 and 99.33% (pyloric ligation), 83.81% and 61.07% (pyloric ligation/acetylcholine), 97.49% and 98.50% (pylorus ligation/histamine); they increased (<i>p</i> &lt; 0.001) the mucus mass and uterine mass. In vitro, the different <i>H. pylori</i> isolates were sensitive to both extracts; the aqueous extract showed strong anti-urease activity, a large diameter of the inhibitory zone and a better minimum inhibitory concentration. Aqueous and methanolic extracts of <i>N. pobeguinii</i> healed ulcers through their estrogen-modulating anti-inflammatory, antioxidant, anti-secretory and cytoprotective properties. The aqueous extract of <i>N. pobeguinii</i> could be a good solution for the treatment of this infection.</p></div>","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"24 1","pages":"223 - 242"},"PeriodicalIF":1.8,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47718669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Traditional medicinal plants used in the treatment of viral diseases 用于治疗病毒性疾病的传统药用植物
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-02 DOI: 10.1007/s13596-023-00687-1
Joachim Djimon Gbenou, Placide Mahougnan Toklo, Mahoudro Fidèle Assogba, Mathias Amour Ahomadegbe, Djidénou Ahoton, Arnaud Davo, Bienvenu Glinma, Mansourou Moudachirou, Dossou Sika Salomé Kpoviessi, Eléonore Chikani Yayi

Nowadays, theoretical chemistry has experienced a great advance in the search for drugs for the treatment of various human and animal pathologies. Although it is expected that medicinal plants constitute a great source for the research of compounds, the present study has been carried out to provide a list of important plants that can be explored in the research of antiviral compounds. The main objective is to search for medicinal plant(s) that can be used to treat various viral pathologies; in other words, the search for broad spectrum antiviral plants. Thus, several articles of synthesis, original research, systematic review on antiviral plants from different countries are consulted in this study. A total of 694 species of medicinal plants from 152 families were extracted from the literature against 17 virus families including Adenoviridae, Alloherpesviridae, Arteriviridae, Birnaviridae, Coronaviridae, Flaviviridae, Herpesviridae, Nimaviridae, Orthomyxoviridae, Papillomaviridae, Parvoviridae, Picornaviridae, Poxviridae, Reoviridae, Retroviridae, Togaviridae. The most cited families of plants are Fabaceae (11.38%), Lamiaceae (5.90%), Asteraceae (5.61%), Rubiaceae (3.45%) and Euphorbiaceae (3.02%). The three (3) most cited species that can treat several viral diseases are Allium sativum, Azadirachta indica and Zingiber officinale. These plants can be a starting point for antiviral drug research and the compounds already isolated from these plants can be subject to molecular docking in order to explore their antiviral potential.

如今,理论化学在寻找治疗各种人类和动物疾病的药物方面取得了巨大进步。虽然药用植物有望成为化合物研究的重要来源,但本研究旨在提供一份可用于抗病毒化合物研究的重要植物清单。主要目的是寻找可用于治疗各种病毒性疾病的药用植物;换句话说,就是寻找广谱抗病毒植物。因此,本研究参考了不同国家关于抗病毒植物的多篇综述、原创研究和系统综述文章。Birnaviridae, Coronaviridae, Flaviviridae, Herpesviridae, Nimaviridae, Orthomyxoviridae, Papillomaviridae, Parvoviridae, Picornaviridae, Poxviridae, Reoviridae, Retroviridae, Togaviridae。被引用最多的植物科是豆科(11.38%)、唇形科(5.90%)、菊科(5.61%)、茜草科(3.45%)和大戟科(3.02%)。能治疗多种病毒性疾病的最常引用的三(3)种植物是葱属(Allium sativum)、杜鹃花属(Azadirachta indica)和细辛属(Zingiber officinale)。这些植物可以作为抗病毒药物研究的起点,已经从这些植物中分离出来的化合物可以进行分子对接,以探索其抗病毒潜力。
{"title":"Traditional medicinal plants used in the treatment of viral diseases","authors":"Joachim Djimon Gbenou,&nbsp;Placide Mahougnan Toklo,&nbsp;Mahoudro Fidèle Assogba,&nbsp;Mathias Amour Ahomadegbe,&nbsp;Djidénou Ahoton,&nbsp;Arnaud Davo,&nbsp;Bienvenu Glinma,&nbsp;Mansourou Moudachirou,&nbsp;Dossou Sika Salomé Kpoviessi,&nbsp;Eléonore Chikani Yayi","doi":"10.1007/s13596-023-00687-1","DOIUrl":"10.1007/s13596-023-00687-1","url":null,"abstract":"<div><p>Nowadays, theoretical chemistry has experienced a great advance in the search for drugs for the treatment of various human and animal pathologies. Although it is expected that medicinal plants constitute a great source for the research of compounds, the present study has been carried out to provide a list of important plants that can be explored in the research of antiviral compounds. The main objective is to search for medicinal plant(s) that can be used to treat various viral pathologies; in other words, the search for broad spectrum antiviral plants. Thus, several articles of synthesis, original research, systematic review on antiviral plants from different countries are consulted in this study. A total of 694 species of medicinal plants from 152 families were extracted from the literature against 17 virus families including Adenoviridae, Alloherpesviridae, Arteriviridae, Birnaviridae, Coronaviridae, Flaviviridae, Herpesviridae, Nimaviridae, Orthomyxoviridae, Papillomaviridae, Parvoviridae, Picornaviridae, Poxviridae, Reoviridae, Retroviridae, Togaviridae. The most cited families of plants are Fabaceae (11.38%), Lamiaceae (5.90%), Asteraceae (5.61%), Rubiaceae (3.45%) and Euphorbiaceae (3.02%). The three (3) most cited species that can treat several viral diseases are <i>Allium sativum</i>, <i>Azadirachta indica</i> and <i>Zingiber officinale</i>. These plants can be a starting point for antiviral drug research and the compounds already isolated from these plants can be subject to molecular docking in order to explore their antiviral potential.</p></div>","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"24 1","pages":"99 - 131"},"PeriodicalIF":1.8,"publicationDate":"2023-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42152399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Water hyacinth (Eichhornia crassipes) fractions potentially normalize the lead (Pb) poisoning and enhance in vitro thrombolysis 更正:凤眼莲组分可能使铅中毒正常化,并增强体外溶栓作用
IF 2 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-07-01 DOI: 10.1007/s13596-023-00690-6
A. M. Abu Ahmed, Sarowar Jahan Khan, Nipun Mojumder, Farjana Sharmen, Md. Atiar Rahman, Muhammad Abu Bakar, J. M. Kamirul Hasan Chowdhury, Mohammad Ali Azadi
{"title":"Correction: Water hyacinth (Eichhornia crassipes) fractions potentially normalize the lead (Pb) poisoning and enhance in vitro thrombolysis","authors":"A. M. Abu Ahmed,&nbsp;Sarowar Jahan Khan,&nbsp;Nipun Mojumder,&nbsp;Farjana Sharmen,&nbsp;Md. Atiar Rahman,&nbsp;Muhammad Abu Bakar,&nbsp;J. M. Kamirul Hasan Chowdhury,&nbsp;Mohammad Ali Azadi","doi":"10.1007/s13596-023-00690-6","DOIUrl":"10.1007/s13596-023-00690-6","url":null,"abstract":"","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"23 3","pages":"951 - 951"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43617697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethnomedicinal review of plants utilized by the Abagusii people of Western Kenya 肯尼亚西部 Abagusii 人使用的植物民族药用综述
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-06-21 DOI: 10.1007/s13596-023-00689-z
Jared Misonge Onyancha, Gervason Apiri Moriasi, Vincent Obaga Nyandoro, Brenda Monchara Onyancha, James Meroka Onsinyo

The Abagusii people of Western Kenya have rich traditional medicine practices which have remained scantly documented. The current study sort to review relevant ethnomedicinal information which was extracted from relevantbooks, journals and theses that were published before March 2021. Also, online electronic databases accessed between April 2020 to March 2021 were used. After identifying potential literature sources, an inventory of medicinal plants used by the Abagusii community was created using Excel Spreadsheet (Microsoft 365) and analyzed qualitatively. Informant Consensus Factor values were computed as a measure of homogeneity. Two hundred and fifteen plant species, mostly belonging to Asteraceae, Fabaceae, Lamiaceae, and Solanaceae families, were identified and 870 use reports were documented. Further, our findings revealed that most plants were used to treat intestinal/gastric diseases, skin infections, disorders, musculoskeletal disorders, and syndromes. Plant parts and forms used commonly were the leaves and herbs, respectively. The Abagusii people mostly prepare plant medicines as decoctions, often for drinking orally to treat diseases. It was noted that there was substantial sharing of ethnomedicinal information on various diseases among the people of Kisii and Nyamira Counties, except for anthrax, cancer, cardiovascular disorders, and evil eyes conditions, which lacked homogeneity. Our study revealed the integral role of medicinal plants in promoting health among the Abagusii community of Kenya in managing various diseases. Our study lays a framework for empirical studies towards validating medical plants of the Abagusii people managing various ailments and potential development of alternative, efficacious, affordable, accessible, and safe therapeutic remedies.

肯尼亚西部的 Abagusii 人拥有丰富的传统医药实践,但这些实践的记录却很少。本研究从 2021 年 3 月之前出版的相关书籍、期刊和论文中提取了相关的民族医药信息。此外,还使用了 2020 年 4 月至 2021 年 3 月期间访问的在线电子数据库。在确定潜在的文献来源后,使用 Excel 电子表格(Microsoft 365)创建了 Abagusii 社区使用的药用植物清单,并进行了定性分析。计算了信息提供者共识因子值,作为衡量同质性的标准。我们确定了 215 种植物,其中大部分属于菊科、豆科、茄科和茄属植物,并记录了 870 份使用报告。此外,我们的研究结果表明,大多数植物被用于治疗肠道/胃部疾病、皮肤感染、失调、肌肉骨骼疾病和综合症。常用的植物部位和形态分别是叶子和草药。Abagusii 人通常将植物药煎煮后饮用,以治疗疾病。我们注意到,除了炭疽病、癌症、心血管疾病和邪眼病缺乏同质性之外,基西县和尼阿米拉县的人们在各种疾病的民族医药信息方面有很大的共享性。我们的研究揭示了药用植物在促进肯尼亚 Abagusii 族群健康、控制各种疾病方面发挥的不可或缺的作用。我们的研究为验证 Abagusii 人治疗各种疾病的药用植物以及潜在的替代、有效、可负担、可获得和安全的治疗方法的开发奠定了实证研究的框架。
{"title":"Ethnomedicinal review of plants utilized by the Abagusii people of Western Kenya","authors":"Jared Misonge Onyancha,&nbsp;Gervason Apiri Moriasi,&nbsp;Vincent Obaga Nyandoro,&nbsp;Brenda Monchara Onyancha,&nbsp;James Meroka Onsinyo","doi":"10.1007/s13596-023-00689-z","DOIUrl":"10.1007/s13596-023-00689-z","url":null,"abstract":"<div><p>The Abagusii people of Western Kenya have rich traditional medicine practices which have remained scantly documented. The current study sort to review relevant ethnomedicinal information which was extracted from relevantbooks, journals and theses that were published before March 2021. Also, online electronic databases accessed between April 2020 to March 2021 were used. After identifying potential literature sources, an inventory of medicinal plants used by the Abagusii community was created using Excel Spreadsheet (Microsoft 365) and analyzed qualitatively. Informant Consensus Factor values were computed as a measure of homogeneity. Two hundred and fifteen plant species, mostly belonging to Asteraceae, Fabaceae, Lamiaceae, and Solanaceae families, were identified and 870 use reports were documented. Further, our findings revealed that most plants were used to treat intestinal/gastric diseases, skin infections, disorders, musculoskeletal disorders, and syndromes. Plant parts and forms used commonly were the leaves and herbs, respectively. The Abagusii people mostly prepare plant medicines as decoctions, often for drinking orally to treat diseases. It was noted that there was substantial sharing of ethnomedicinal information on various diseases among the people of Kisii and Nyamira Counties, except for anthrax, cancer, cardiovascular disorders, and evil eyes conditions, which lacked homogeneity. Our study revealed the integral role of medicinal plants in promoting health among the Abagusii community of Kenya in managing various diseases. Our study lays a framework for empirical studies towards validating medical plants of the Abagusii people managing various ailments and potential development of alternative, efficacious, affordable, accessible, and safe therapeutic remedies.</p></div>","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"24 1","pages":"67 - 97"},"PeriodicalIF":1.8,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136355585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polydatin as a potential candidate that alleviates lead poisoning: insights from biochemical and oxidative damage in lead-induced Wistar rats Polydatin作为缓解铅中毒的潜在候选药物:从铅诱导的Wistar大鼠的生化和氧化损伤中获得的见解
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-06-12 DOI: 10.1007/s13596-023-00688-0
Salisu M. Highab, Jamilu Ya’u, Muhammad G. Magaji, Dalhatu M. Shehu

Lead is one of the most common heavy metal elements and has high biological toxicity. Polydatin (PD), also known as piceid (3, 4′, 5-trihydroxystilbene-3-β-D-glucoside), is a monocrystalline compound isolated from Polygonum cuspidatum Sieb. et Zucc. (Polygonaceae), but is also found in fruits and many daily diets. Aim of this research is polydatin as a potential candidate that alleviates lead poisoning: insights from biochemical and oxidative damage in lead-Induced Wistar rats. The study employed 42 Wistar rats of 90 days of age (150–200 g) which were randomly divided into six (6) groups and used for sub-chronic toxicity study according to OECD 407 guideline were lead acetate (PbAc) was administered for 90 days and followed by treatment with PD for 30 days. Control DW (1 mL/kg); PbAc (120 mg/kg); PbAc (120 mg/kg) + PD (250 mg/kg); PbAc (120 mg/kg) + PD (500 mg/kg); PbAc (120 mg/kg) + PD (1000 mg/kg); and PbAc (120 mg/kg) + DMSA (10 mg/kg) daily for 16 weeks per oral. At the end of treatment period, blood, plasma and organs samples were evaluated for blood lead levels (BLLs), biochemical parameters, oxidative stress markers and histopathology. PD and DMSA significantly (p < 0.05) reduced liver indices of PbAc-induced toxicity in rats with the exceptions of total and direct bilirubin which were significantly (p < 0.05) elevated. PD and DMSA significantly (p < 0.05) restored levels of renal indices and lipid profiles in PbAc-induced toxicity in rats by reducing the levels in serum and the effects were dose depended in all parameters. Furthermore, PD and DMSA also alleviate PbAc-induced MDA, GSH levels and inhibition of CAT and SOD in rats. PD alleviates lead poisoning through its ability to improve biochemical and oxidative damage in lead-induced rats. The overall findings shows that polydatin alleviates lead poisoning which might be due its ability to improve biochemical and oxidative damage through stabilizing the levels GSH, MDA and activities of SOD, CAT in lead-induced toxicity in Wistar rats.

铅是最常见的重金属元素之一,具有很高的生物毒性。多靛素(PD),又称 piceid(3, 4′, 5-三羟基二苯乙烯-3-β-D-葡萄糖苷),是一种从蓼科植物蓼(Polygonum cuspidatum Sieb. et Zucc.)中分离出来的单晶化合物,也存在于水果和许多日常饮食中。这项研究的目的是将多靛红作为缓解铅中毒的潜在候选物质:从铅诱导的 Wistar 大鼠的生化和氧化损伤中获得启示。研究采用了 42 只 90 天大的 Wistar 大鼠(150-200 克),将其随机分为六(6)组,并根据 OECD 407 准则进行亚慢性毒性研究。对照组 DW(1 毫升/千克);PbAc(120 毫克/千克);PbAc(120 毫克/千克)+ PD(250 毫克/千克);PbAc(120 毫克/千克)+ PD(500 毫克/千克);PbAc(120 毫克/千克)+ PD(1000 毫克/千克);PbAc(120 毫克/千克)+ DMSA(10 毫克/千克),每天口服,共 16 周。治疗结束时,对血液、血浆和器官样本进行血铅含量(BLLs)、生化指标、氧化应激标记物和组织病理学评估。除总胆红素和直接胆红素明显升高(p < 0.05)外,PD 和 DMSA 能明显降低 PbAc 诱导的大鼠肝脏毒性指标(p < 0.05)。PD 和 DMSA 通过降低血清中铅酸诱导毒性大鼠的肾脏指数和脂质概况的水平,明显(p < 0.05)恢复了这些指数和概况的水平,并且所有参数的影响都与剂量有关。此外,PD 和 DMSA 还能缓解 PbAc 诱导的大鼠 MDA、GSH 水平以及 CAT 和 SOD 的抑制作用。多效萘能改善铅诱导大鼠的生化和氧化损伤,从而缓解铅中毒。总的研究结果表明,多靛红能减轻铅中毒,这可能是因为它能通过稳定铅诱导的 Wistar 大鼠体内 GSH、MDA 水平以及 SOD、CAT 的活性来改善生化和氧化损伤。
{"title":"Polydatin as a potential candidate that alleviates lead poisoning: insights from biochemical and oxidative damage in lead-induced Wistar rats","authors":"Salisu M. Highab,&nbsp;Jamilu Ya’u,&nbsp;Muhammad G. Magaji,&nbsp;Dalhatu M. Shehu","doi":"10.1007/s13596-023-00688-0","DOIUrl":"10.1007/s13596-023-00688-0","url":null,"abstract":"<div><p>Lead is one of the most common heavy metal elements and has high biological toxicity. Polydatin (PD), also known as piceid (3, 4′, 5-trihydroxystilbene-3-β-D-glucoside), is a monocrystalline compound isolated from <i>Polygonum cuspidatum</i> Sieb. et Zucc. (Polygonaceae), but is also found in fruits and many daily diets. Aim of this research is polydatin as a potential candidate that alleviates lead poisoning: insights from biochemical and oxidative damage in lead-Induced Wistar rats. The study employed 42 Wistar rats of 90 days of age (150–200 g) which were randomly divided into six (6) groups and used for sub-chronic toxicity study according to OECD 407 guideline were lead acetate (PbAc) was administered for 90 days and followed by treatment with PD for 30 days. Control DW (1 mL/kg); PbAc (120 mg/kg); PbAc (120 mg/kg) + PD (250 mg/kg); PbAc (120 mg/kg) + PD (500 mg/kg); PbAc (120 mg/kg) + PD (1000 mg/kg); and PbAc (120 mg/kg) + DMSA (10 mg/kg) daily for 16 weeks per oral. At the end of treatment period, blood, plasma and organs samples were evaluated for blood lead levels (BLLs), biochemical parameters, oxidative stress markers and histopathology. PD and DMSA significantly (<i>p</i> &lt; 0.05) reduced liver indices of PbAc-induced toxicity in rats with the exceptions of total and direct bilirubin which were significantly (<i>p</i> &lt; 0.05) elevated. PD and DMSA significantly (<i>p</i> &lt; 0.05) restored levels of renal indices and lipid profiles in PbAc-induced toxicity in rats by reducing the levels in serum and the effects were dose depended in all parameters. Furthermore, PD and DMSA also alleviate PbAc-induced MDA, GSH levels and inhibition of CAT and SOD in rats. PD alleviates lead poisoning through its ability to improve biochemical and oxidative damage in lead-induced rats. The overall findings shows that polydatin alleviates lead poisoning which might be due its ability to improve biochemical and oxidative damage through stabilizing the levels GSH, MDA and activities of SOD, CAT in lead-induced toxicity in Wistar rats.</p></div>","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"24 1","pages":"211 - 222"},"PeriodicalIF":1.8,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49429468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicinal plants of the Tomsk region and possibilities of their application 托木斯克地区药用植物及其应用的可能性
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-05-08 DOI: 10.1007/s13596-023-00685-3
A. N. Nekratova, N. S. Zinner

As a result of the analysis of the distribution of wild medicinal plants on the territory of the Tomsk region, a list of species used for medical treatment has been formed. The list includes 129 species of medicinal plants belonging to 110 genera and 37 families. The most rich in the composition of medicinal plants used for the treatment of various diseases are the following families: Asteraceae, Ranunculaceae, Apiaceae, Rosaceae, Liliaceae, Brassicaceae, Boraginaceae. Out of 129 species of medicinal plants, 91 species are used in folk medicine, 31 species belong to official medicinal plants, and 27 species are poisonous. In most species, the aboveground part is used (70 species), in 29 species, the underground part is used, in the rest of the plants, separate organs of the aboveground or underground part are used. Of the entire list of medicinal plants, 36 species can be classified as frequently occurring, 20 species as common, 29 species as rare and very rare, and the remaining species are infrequent and rare.

通过对托木斯克州境内野生药用植物分布情况的分析,形成了一份用于医疗的物种清单。该清单包括隶属于 110 属 37 科的 129 种药用植物。用于治疗各种疾病的药用植物中最丰富的是以下科:菊科、毛茛科、繖形花科、蔷薇科、百合科、芸香科、婆婆纳科。在 129 种药用植物中,91 种用于民间医药,31 种属于正式药用植物,27 种有毒。大多数物种使用地上部分(70 种),29 种使用地下部分,其余植物使用地上部分或地下部分的不同器官。在整个药用植物清单中,36 种可归类为经常出现,20 种为常见,29 种为稀有和非常稀有,其余为不常见和稀有。
{"title":"Medicinal plants of the Tomsk region and possibilities of their application","authors":"A. N. Nekratova,&nbsp;N. S. Zinner","doi":"10.1007/s13596-023-00685-3","DOIUrl":"10.1007/s13596-023-00685-3","url":null,"abstract":"<div><p>As a result of the analysis of the distribution of wild medicinal plants on the territory of the Tomsk region, a list of species used for medical treatment has been formed. The list includes 129 species of medicinal plants belonging to 110 genera and 37 families. The most rich in the composition of medicinal plants used for the treatment of various diseases are the following families: <i>Asteraceae</i>, <i>Ranunculaceae</i>, <i>Apiaceae</i>, <i>Rosaceae</i>, <i>Liliaceae</i>, <i>Brassicaceae</i>, <i>Boraginaceae</i>. Out of 129 species of medicinal plants, 91 species are used in folk medicine, 31 species belong to official medicinal plants, and 27 species are poisonous. In most species, the aboveground part is used (70 species), in 29 species, the underground part is used, in the rest of the plants, separate organs of the aboveground or underground part are used. Of the entire list of medicinal plants, 36 species can be classified as frequently occurring, 20 species as common, 29 species as rare and very rare, and the remaining species are infrequent and rare.</p></div>","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"24 1","pages":"41 - 66"},"PeriodicalIF":1.8,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42799444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethnopharmacological survey of aromatic medicinal plants used in the treatment of the most recurrent diseases in the locality of Oyem, Gabon 加蓬Oyem地区用于治疗最常见疾病的芳香药用植物的民族药理学调查
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-05-06 DOI: 10.1007/s13596-023-00684-4
Cédric Sima Obiang, Rick-Léonid Ngoua Meye Misso, Thiery Ndong Mba, Joseph Privat Ondo, Louis Clément Obame Engonga, Edouard Nsi Emvo

Aromatic medicinal plants are a great source of active principles that can be used to treat several diseases. The objective of this study was to identify the aromatic plants used in traditional medicine to treat the most recurrent diseases in the locality of Oyem. An ethnobotanical survey was conducted among traditional healers in Oyem. Descriptive statistical methods were used to analyze the ethnopharmacological survey data and various quantitative indices, including informant consensus factor, use value, relative citation frequency, and level of fidelity. The data collected identified 72 plant species belonging to 23 families. Decoction, infusion and maceration were the three most commonly used methods of preparation. The most commonly used plant parts were leaves and barks. Cough-associated diseases had the highest RCF (0.630). The RCF was highest for Desmodium salicifolium DC (0.0713), The use values (UV) ranged from 0.11 to 0.93. These results provide a good data base for studies on fragrant plants.

芳香药用植物是活性成分的重要来源,可用于治疗多种疾病。本研究的目的是确定传统医学中用于治疗奥耶姆地区最常见疾病的芳香植物。研究人员对奥耶姆的传统治疗师进行了人种植物学调查。采用描述性统计方法分析了民族药理学调查数据和各种定量指标,包括信息提供者共识因子、使用价值、相对引用频率和忠实程度。收集到的数据确定了隶属于 23 个科的 72 种植物。煎煮、灌注和浸渍是三种最常用的配制方法。最常用的植物部位是叶子和树皮。咳嗽相关疾病的 RCF 最高(0.630)。Desmodium salicifolium DC 的 RCF 最高(0.0713),使用值(UV)从 0.11 到 0.93 不等。这些结果为芳香植物研究提供了良好的数据基础。
{"title":"Ethnopharmacological survey of aromatic medicinal plants used in the treatment of the most recurrent diseases in the locality of Oyem, Gabon","authors":"Cédric Sima Obiang,&nbsp;Rick-Léonid Ngoua Meye Misso,&nbsp;Thiery Ndong Mba,&nbsp;Joseph Privat Ondo,&nbsp;Louis Clément Obame Engonga,&nbsp;Edouard Nsi Emvo","doi":"10.1007/s13596-023-00684-4","DOIUrl":"10.1007/s13596-023-00684-4","url":null,"abstract":"<div><p>Aromatic medicinal plants are a great source of active principles that can be used to treat several diseases. The objective of this study was to identify the aromatic plants used in traditional medicine to treat the most recurrent diseases in the locality of Oyem. An ethnobotanical survey was conducted among traditional healers in Oyem. Descriptive statistical methods were used to analyze the ethnopharmacological survey data and various quantitative indices, including informant consensus factor, use value, relative citation frequency, and level of fidelity. The data collected identified 72 plant species belonging to 23 families. Decoction, infusion and maceration were the three most commonly used methods of preparation. The most commonly used plant parts were leaves and barks. Cough-associated diseases had the highest RCF (0.630). The RCF was highest for Desmodium salicifolium DC (0.0713), The use values (UV) ranged from 0.11 to 0.93. These results provide a good data base for studies on fragrant plants.</p></div>","PeriodicalId":7613,"journal":{"name":"Advances in Traditional Medicine","volume":"24 1","pages":"191 - 210"},"PeriodicalIF":1.8,"publicationDate":"2023-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42482835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advances in Traditional Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1